Becton, dickinson and company:1106636 [18-003842]
Ended Awarded
- Contract number
- 75N92B18F00013
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,259
Award facts
- Contract value 100% obligated
- $5,258.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a $5,258.95 firm fixed price Blanket Purchase Agreement (BPA) call award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases on June 14, 2018, with an ultimate completion date of July 31, 2018. The contract was awarded without a set-aside designation and will be performed in Bethesda, Maryland. As a global medical technology manufacturer specializing in flow cytometry instruments, cell imaging systems, and diagnostic reagents, BD Biosciences provides the federal government with sophisticated biomedical research technologies and associated support services across multiple agencies.
BD's federal contracting history demonstrates extensive capabilities in supplying advanced medical equipment and consumables to civilian agencies, including various components of the National Institutes of Health, the Department of Veterans Affairs, and the Centers for Disease Control and Prevention. The company maintains several significant Indefinite Delivery Vehicles with these agencies, including multi-million dollar agreements for flow cytometry systems and reagents. This specific call order represents a small-value procurement utilizing an existing BPA framework, enabling the funding agency to access BD's specialized instrumentation and laboratory support capabilities on an as-needed basis.
Quick answers
Who was awarded contract 75N92B18F00013?
75N92B18F00013 was awarded to Becton, Dickinson And Company by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on June 14, 2018.
How much is contract 75N92B18F00013 worth?
The government has obligated $5,259 on 75N92B18F00013.
Is contract 75N92B18F00013 an order under another contract?
Yes. 75N92B18F00013 is a BPA call under HHSN263201600133B, a blanket purchase agreement.
Was contract 75N92B18F00013 competed?
The extent of competition for 75N92B18F00013 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award